Physician

Vikram A. Grewal, M.D.

According to 2025 Medicare claims, Vikram Grewal, M.D. (NPI: 1528485620) practices cardiology in the Amherst Town-Northampton, MA market, with the plurality of this provider's patient population coming from Hampshire, MA. This provider's primary affiliated billing organization is MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (NPI: 1295787919; TIN: 043194547) and primary practice location at 01060-4272. Grewal is affiliated with the Mass General Brigham ACO, LLC (ACO ID: A4641), participating under the MSSP model.

Grewal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 2,874 traditional Medicare patients, billed 7,029 HCPCS/CPT codes, and received $399,589 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 6,305 prescription claims across 982 beneficiaries totaling $1,701,930 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 90 records totaling $2,257. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $45,071 to $1,701,930. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	373	627	$31,954
2021	2,652	5,948	$419,975
2022	2,820	6,492	$491,211
2023	2,560	5,731	$359,756
2024	2,874	7,029	$399,589

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	49	371	$45,071
2016	78	378	$49,020
2017	82	442	$40,499
2018	43	128	$8,863
2019	29	97	$12,853
2020	37	52	$7,318
2021	594	2,458	$437,063
2022	765	4,201	$894,061
2023	887	5,017	$1,330,292
2024	982	6,305	$1,701,930

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	1,349	1,806	$92
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	347	368	$52
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	468	500	$13
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	893	921	$11
93010	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only	999	1,315	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	574	40,435	$754,497
Xarelto	Rivaroxaban	248	16,137	$289,321
Entresto	Sacubitril/Valsartan	103	8,279	$176,390
Repatha Sureclick	Evolocumab	154	8,449	$157,155
Praluent Pen	Alirocumab	53	3,108	$52,465

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	90	$2,257	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Vikram A. Grewal, M.D.?

Tedicare shows public-source Medicare data for Vikram A. Grewal, M.D. (NPI 1528485620), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Vikram A. Grewal, M.D. have ACO affiliation data?

Vikram A. Grewal, M.D. is shown with ACO affiliation data for Mass General Brigham ACO, LLC (MSSP, ACO ID A4641).

What billing organization is linked to Vikram A. Grewal, M.D.?

Vikram A. Grewal, M.D. is linked to MASS GENERAL BRIGHAM MEDICAL GROUP WESTERN MASSACHUSETTS INC (billing NPI 1295787919) in the available physician profile data.

Does Vikram A. Grewal, M.D. have Open Payments data?

Vikram A. Grewal, M.D. has 90 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.